| 000 | 00907 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250517214704.0 | ||
| 264 | 0 | _c20190318 | |
| 008 | 201903s 0 0 eng d | ||
| 022 | _a1474-5488 | ||
| 024 | 7 |
_a10.1016/S1470-2045(18)30248-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFennell, Dean A | |
| 245 | 0 | 0 |
_aTargeting the tumour vasculature in mesothelioma. _h[electronic resource] |
| 260 |
_bThe Lancet. Oncology _c06 2018 |
||
| 300 |
_a723-724 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Comment | ||
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLung Neoplasms |
| 650 | 0 | 4 | _aMesothelioma |
| 650 | 0 | 4 | _aRecombinant Fusion Proteins |
| 650 | 0 | 4 | _aTumor Necrosis Factor-alpha |
| 773 | 0 |
_tThe Lancet. Oncology _gvol. 19 _gno. 6 _gp. 723-724 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S1470-2045(18)30248-1 _zAvailable from publisher's website |
| 999 |
_c28383907 _d28383907 |
||